Advertisement

Nutritive und toxische Neuropathien

  • J. M. Schröder

Zusammenfassung

Die bekannteste, wenn auch nicht ausschließlich durch Thiaminmangel verursachte Vitaminmangelkrankheit ist Beriberi bei thiaminarmer, kohlenhydratreicher Kost aus geschältem Reis. Zu unterscheiden sind eine schnellverlaufende, nasse Form, die durch kardiale Symptome gekennzeichnet ist und häufiger Kinder befällt, und die chronische, trockene Form, die durch eine akrodistal betonte symmetrische sensomotorische Polyneuropathie charakterisiert ist.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abou-Donia M B, Lapadula D M (1990) Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu Rev Pharmacol Toxicol 30: 405–440PubMedCrossRefGoogle Scholar
  2. Apfel S C, Arezzo J C, Lipson L, Kessler J A (1992) Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31: 76–80PubMedCrossRefGoogle Scholar
  3. Bartz-Bazzanella P, Genth E, Pollmann H J, Schröder J M, Völker A (1992) Eosinophilie-Myalgie-Syndrom mit Fasziitis und interstitieller Myositis nach L-Tryptophan-Einnahme. Z Rheumatol 51: 3–13PubMedGoogle Scholar
  4. Bean W B, Hodges R E, Daum K E (1955) Panthothenic acid deficiency induced in human subjects. J Clin Investig 34: 1073–1084PubMedCrossRefGoogle Scholar
  5. Berger A R, Schaumburg H H, Schroeder C, Apfel S, Reynolds R (1992) Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology 42: 1367–1370PubMedGoogle Scholar
  6. Blass J P, Gibson G E (1977) Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med 297: 1367–1370PubMedCrossRefGoogle Scholar
  7. Bosch E P, Pelham R W, Rasool C G et al. (1979) Animal models of alcoholic neuropathy: morphologic, electrophysiologic, and biochemical findings. Muscle Nerve 2: 133–144PubMedCrossRefGoogle Scholar
  8. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D (1992) Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin ( DDP) administration in rats. Acta Neuropathol (Berl) 84: 364–371CrossRefGoogle Scholar
  9. Cavanagh J B, Buxton P H (1989) Trichloroethylene cranial neuropathy: is it really a toxic neuropathy or does it activate latent herpes virus? J Neurol Neurosurg Psychiatry 52: 297–303PubMedCrossRefGoogle Scholar
  10. Challenor Y B, Richter R W, Bruun B, Pearson J (1973) Non-traumatic plexitis and heroin addiction. Jama 225: 958–961PubMedCrossRefGoogle Scholar
  11. De Bleecker J L, De Reuck J L, Willems J L (1992) Neurological aspects of organophosphate poisoning. Clin Neurol Neurosurg 94: 93–103PubMedCrossRefGoogle Scholar
  12. De Jesus P V Jr, Pleasure D E (1973) Hexachlorophene neuropathy. Arch Neurol 29: 180–182Google Scholar
  13. Dyck P J, Thomas P K, Griffin J W, Low P A, Poduslo J F (1993) Peripheral neuropathy, 3rd edn. Saunders, PhiladelphiaGoogle Scholar
  14. Fine E J, Soria E, Paroski M W, Petryk D, Thomasula L (1990) The neurophysiological profile of vitamin B12 deficiency. Muscle Nerve 13: 158–164PubMedCrossRefGoogle Scholar
  15. Goebel H H, Schmidt P F, Bohl J, Tettenborn B, Kramer G, Gutmann L (1990) Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol 49: 137–149PubMedCrossRefGoogle Scholar
  16. Gombault A (1880) Contribution a l’étude anatomique de la névrite parenchymateuse subaigue ou chronique. — Névrite segmentaire péri-axile (suite). Arch Neurol (Paris) I: 177–190Google Scholar
  17. Griffin J W, Gold B G, Cork L C, Price D L, Lowndes H E (1982) IDPN neuropathy in the cat: coexistence of proximal and distal axonal swellings. Neuropathol Appl Neurobiol 8: 351–364PubMedCrossRefGoogle Scholar
  18. Günzler V (1992) Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations. Drug Saf 7: 116–134PubMedCrossRefGoogle Scholar
  19. Hallett M, Fox J G, Rogers A E et al. (1987) Controlled studies on the effects of alcohol ingestion on peripheral nerves of macaque monkeys. J Neurol Sei 80: 65–71PubMedCrossRefGoogle Scholar
  20. Hoffmann P N, Griffin J W (1993) The control of axonal caliber. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy, vol 1. Saunders, Philadelphia, pp 389–402Google Scholar
  21. Johnson M K (1990) Organophosphates and delayed neuropathy — is NTE alive and well? Toxicol Appl Pharmacol 102: 385–399PubMedCrossRefGoogle Scholar
  22. Kalichman M W, Powell H C, Myers R R (1988) Pathology of local anesthetic-induced nerve injury. Acta Neuropathol (Berl) 75: 583–589CrossRefGoogle Scholar
  23. Kilbourne E M, Rigau-Perez J G, Heath C W Jr et al. (1983) Clinical epidemiology of toxic-oil syndrome. Manifestations of a new illness. N Engl J Med 309: 1408–1414PubMedCrossRefGoogle Scholar
  24. Klinghardt G W (1974) Das Perineurium als Diffusionsbarriere gegenüber Peroxydase bei epi- und endoneuraler Applikation. Acta Neuropathol (Berl) 28: 117–41CrossRefGoogle Scholar
  25. Krinke G, Naylor D C, Skorpil V (1985) Pyridoxine megavitaminosis: an analysis of the early changes induced with massive doses of vitamin B6 in rat primary sensory neurons. J Neuropathol Exp Neurol 44: 117–129PubMedCrossRefGoogle Scholar
  26. Krücke W, Hartrott H H v, Schröder J M, Thomas E, Gibbels E, Scheid W (1971) Licht- und elektronenmikroskopische Untersuchungen zum Spätstadium der Thalidomidneuropathie. Fortschr Neurol Psychiatr Grenzgeb 39: 15–50PubMedGoogle Scholar
  27. Kuzuhara S, Kanazawa I, Nakanishi T, Egashira T (1983) Ethylene oxide polyneuropathy. Neurology 33: 377–380PubMedGoogle Scholar
  28. Lehnert H (1990) Eosinophilie-Myalgie-Syndrom und Einnahme L-Tryptophan-haltiger Arzneimittel. Dt Ärztebl 87: C-1255–C-11257Google Scholar
  29. Lipton R B, Apfel S C, Dutcher J P et al. (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39: 368–373PubMedGoogle Scholar
  30. Mateo I M, Izquierdo M, Fernandez-Dapica M P, Navas J, Cabello A, Gomez-Reino J J (1984) Toxic epidemic syndrome: musculoskeletal manifestations. J Rheumatol 11: 333–338PubMedGoogle Scholar
  31. Meier C, Kauer B, Müller U, Ludin H P (1979) Neuromyopathy during chronic amiodarone treatment. A case report. J Neurol 220: 231–239PubMedCrossRefGoogle Scholar
  32. Neundörfer B (1987) Polyneuritiden und Polyneuropathien. In: Neundörfer B, Schimrigk K, Soyka D, (Hrsg) Praktische Neurologie, Bd 2. VCH, WeinheimGoogle Scholar
  33. Ogawa M (1971) Electrophysiological and histological studies of experimental chlorobiphenyl poisoning. Fukuoka Acta Med 62: 74–78Google Scholar
  34. Ohnishi A, Tsuji S, Igisu H et al. (1980) Beriberi neuropathy. Morphometric study of sural nerve. J Neurol Sci 45: 177–190PubMedCrossRefGoogle Scholar
  35. Prineas J (1970) Peripheral nerve changes in thiamine-deficient rats. An electron microscope study. Arch Neurol 23: 541–548PubMedGoogle Scholar
  36. Riggs J E, Ashraf M, Snyder R D, Gutmann L (1988) Prospective nerve conduction studies in cisplatin therapy. Ann Neurol 23: 92–94PubMedCrossRefGoogle Scholar
  37. Rommelspacher H, Wanke K, Caspari D, Topel H (1989) Al-koholismusforschung im internationen Vergleich. Dt Ärztebl 86: B-2197–2204Google Scholar
  38. Röyttä M, Raine C S (1986) Taxol-induced neuropathy: chronic effects of local injection. J Neurocytol 15: 483–496PubMedCrossRefGoogle Scholar
  39. Schaumburg H H, Berger A R, Thomas P K (1992) Disorders of peripheral nerves, 2nd edn. Davis, PhiladelphiaGoogle Scholar
  40. Schröder JM (1968) Die Hyperneurotisation Büngnerscher Bänder bei der experimentellen Isoniazid-Neuropathie: Phasenkontrast- und elektronenmikroskopische Untersuchungen. Virch Arch Abt B Zellpath 1: 131–156Google Scholar
  41. Schröder J M (1970 a) Zur Feinstruktur und quantitativen Auswertung regenerierter peripherer Nervenfasern. Proceedings of the VIth International Congress of Neuropathology, Paris 1970, pp 628–646Google Scholar
  42. Schröder J M (1970 b) Zur Pathogenese der Isoniazid-Neuropathie. I. Eine feinstrukturelle Differenzierung gegenüber der Wallerschen Degeneration. Acta Neuropathol 16: 301– 323Google Scholar
  43. Schröder J M (1970 c) Zur Pathogenese der Isoniazid-Neuro-pathie. II. Phasenkontrast- und elektronenmikroskopische Untersuchungen am Rückenmark, an den Spinalganglien und Muskelspindeln. Acta Neuropathol 16: 324–341Google Scholar
  44. Schröder J M ( 2000 a) Cadmium. In: Spencer PS, Schaumburg HS (eds) Experimental and clinical neurotoxicology. Oxford University Press, pp 276–280Google Scholar
  45. Schröder J M ( 2000 b) Isoniazid. In: Spencer PS, Schaumburg HS (eds) Experimental and clinical neurotoxicology. Oxford University Press, pp 690–697Google Scholar
  46. Schröder J M, Himmelmann F (1992) Fine structural evaluation of altered Schmidt-Lanterman incisures in human sural nerve biopsies. Acta Neuropathol (Berl) 83: 120–133CrossRefGoogle Scholar
  47. Schröder J M, Matthiesen T (1985) Experimental thalidomide neuropathy: the morphological correlate of reduced conduction velocity. Acta Neuropathol (Berl) 65: 285–92CrossRefGoogle Scholar
  48. Schröder J M, Hoheneck M, Weis J, Deist H (1985) Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol 232: 83–90PubMedCrossRefGoogle Scholar
  49. Schröder J M, Huffmann B, Braun V, Richter H P (1992) Spasmodic torticollis: severe compression neuropathy in rami dorsales of cervical nerves CI-6. Acta Neuropathol (Berl) 84: 416–424CrossRefGoogle Scholar
  50. Schröder J M, Sellhaus B, Wöhrmann T, Kögel B, Zwingenberger K (1995) Inhibitory effects of thalidomide on cellular proliferation, endoneurial edema and myelin phagocytosis during early wallerian degeneration. Acta Neuropathol (Berl) 89: 415–419CrossRefGoogle Scholar
  51. Seidman R J, Kaufman L D, Sokoloff L, Miller F, Iliya A, Peress N S (1991) The neuromuscular pathology of the eosinophilia-myalgia syndrome. J Neuropathol Exp Neurol 50: 49–62PubMedCrossRefGoogle Scholar
  52. Slutsker L, Hoesly F C, Miller L, Williams L P, Watson J C, Fleming D W (1990) Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. Jama 264: 213–217PubMedCrossRefGoogle Scholar
  53. Smith B E, Dyck P J (1990) Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion (see comments). Neurology 40: 1035–40PubMedGoogle Scholar
  54. Smith W, Wilson AF (1975) Guillan-Barre syndrome in heroin addiction. Jama 231: 1367–1368PubMedCrossRefGoogle Scholar
  55. Spencer P S, Schaumburg H H (eds) (2000) Experimental and clinical neurotoxicology, 2nd edn. Oxford University PressGoogle Scholar
  56. Stevens H, Forster F M (1953) Effect of carbon tetrachloroide on the nervous system. AMA Arch Neurol Psychiatry 70: 635–649PubMedGoogle Scholar
  57. Swygert L A, Maes E F, Sewell L E, Miller L, Falk H, Kilbourne E M (1990) Eosinophilia-myalgia syndrome. Results of National Surveillance. JAMA 264: 1698–1703PubMedCrossRefGoogle Scholar
  58. Tabaraud F, Vallat J M, Hugon J, Ramiandrisoa H, Dumas M, Signoret J L (1990) Acute or subacute alcoholic neuropathy mimicking Guillain-Barre syndrome. J Neurol Sci 97: 195–205PubMedCrossRefGoogle Scholar
  59. Thomas P K, Landon D N, King R H M (1997) Diseases of the peripheral nerves. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology, vol 2. Arnold, London, pp 367–487Google Scholar
  60. Tischner K H, Schroder J M (1972) The effects of cadmium chloride on organotypic cultures of rat sensory ganglia. A light and electron microscope study. J Neurol Sci 16: 383–399PubMedCrossRefGoogle Scholar
  61. Vinken P J, Bruyn G W (eds) (1994/1995). Intoxications of the nervous system. Elsevier, Amsterdam (Handbook Clin Neurol, vol 64/65)Google Scholar
  62. Vuorinen V S, Röyttä M (1990) Taxol-induced neuropathy after nerve crush: long-term effects on Schwann and endoneurial cells. Acta Neuropathol (Berl) 79: 653–662CrossRefGoogle Scholar
  63. Windebank A (1993) Polyneuropathy due to nutritional deficiency and alcoholism. In: Dyck P, Thomas P, Griffin J, Low P, Poduslo J (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 1310–1321Google Scholar
  64. Yokota T, Wada Y, Furukawa T, Tsukagoshi H, Uchihara T, Watabiki S (1987) Adult-onset spinocerebellar syndrome with idiopathic vitamin E deficiency. Ann Neurol 22: 84–87CrossRefGoogle Scholar
  65. Yokoyama K, Araki S, Abe H (1990) Distribution of nerve conduction velocities in acute thallium poisoning. Muscle Nerve 13: 117–120PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • J. M. Schröder

There are no affiliations available

Personalised recommendations